(Q37881037)

English

Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation

scientific article published on December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation (English)

1 reference

Europe PubMed Central

24 August 2017

atrial fibrillation

0 references

author name string

Anique Ducharme

1

1 reference

Europe PubMed Central

24 August 2017

Ernesto L Schiffrin

2

1 reference

Europe PubMed Central

24 August 2017

publication date

1 December 2010

1 reference

Europe PubMed Central

24 August 2017

The Canadian Journal of Cardiology

1 reference

Europe PubMed Central

24 August 2017

26 Suppl E

1 reference

Europe PubMed Central

24 August 2017

21E-23E

1 reference

Europe PubMed Central

24 August 2017

Epidemiologic features of chronic atrial fibrillation: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial electrophysiologic remodeling: another vicious circle?

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Irbesartan in patients with heart failure and preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of lisinopril in patients with heart failure and chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan and prevention of atrial fibrillation recurrence in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan for prevention of recurrent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Candesartan in the prevention of relapsing atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0828-282X(10)71170-3

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37881037&oldid=1746646410"